McKenna WG - Search Results

1

Detection of hypoxia in human squamous cell carcinoma by EF5 binding.

Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, Koch CJ. Evans SM, et al. Among authors: mckenna wg. Cancer Res. 2000 Apr 1;60(7):2018-24. Cancer Res. 2000. PMID: 10766193 Clinical Trial.

2

Hypoxia in human intraperitoneal and extremity sarcomas.

Evans SM, Hahn SM, Magarelli DP, Zhang PJ, Jenkins WT, Fraker DL, Hsi RA, McKenna WG, Koch CJ. Evans SM, et al. Among authors: mckenna wg. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):587-96. doi: 10.1016/s0360-3016(00)01494-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173159 Clinical Trial.

3

The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.

Cohen-Jonathan E, Evans SM, Koch CJ, Muschel RJ, McKenna WG, Wu J, Bernhard EJ. Cohen-Jonathan E, et al. Among authors: mckenna wg. Cancer Res. 2001 Mar 1;61(5):2289-93. Cancer Res. 2001. PMID: 11280800

4

Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles.

Koch CJ, Hahn SM, Rockwell K Jr, Covey JM, McKenna WG, Evans SM. Koch CJ, et al. Among authors: mckenna wg. Cancer Chemother Pharmacol. 2001 Sep;48(3):177-87. doi: 10.1007/s002800100324. Cancer Chemother Pharmacol. 2001. PMID: 11592338 Clinical Trial.

5

Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signaling.

Muschel RJ, Bernhard EJ, Garza L, McKenna WG, Koch CJ. Muschel RJ, et al. Among authors: mckenna wg. Cancer Res. 1995 Mar 1;55(5):995-8. Cancer Res. 1995. PMID: 7867011

6

A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.

Hahn SM, Bernhard EJ, Regine W, Mohiuddin M, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, DeLaney TF, Kiel KD, Morrison B, Deutsch P, Muschel RJ, McKenna WG. Hahn SM, et al. Among authors: mckenna wg. Clin Cancer Res. 2002 May;8(5):1065-72. Clin Cancer Res. 2002. PMID: 12006520 Clinical Trial.

7

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.

Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ. Brunner TB, et al. Among authors: mckenna wg. Cancer Res. 2003 Sep 15;63(18):5656-68. Cancer Res. 2003. PMID: 14522880 Review.

8

Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.

Brunner TB, Cengel KA, Hahn SM, Wu J, Fraker DL, McKenna WG, Bernhard EJ. Brunner TB, et al. Among authors: mckenna wg. Cancer Res. 2005 Sep 15;65(18):8433-41. doi: 10.1158/0008-5472.CAN-05-0158. Cancer Res. 2005. PMID: 16166322

9

Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS, Muschel RJ. Gupta AK, et al. Among authors: mckenna wg. Clin Cancer Res. 2002 Mar;8(3):885-92. Clin Cancer Res. 2002. PMID: 11895923 Clinical Trial.

10

Ras inhibitors and radiation therapy.

Jones HA, Hahn SM, Bernhard E, McKenna WG. Jones HA, et al. Among authors: mckenna wg. Semin Radiat Oncol. 2001 Oct;11(4):328-37. doi: 10.1053/srao.2001.26020. Semin Radiat Oncol. 2001. PMID: 11677657 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters